Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
暂无分享,去创建一个
S. Bangalore | A. Chapman | L. Inker | G. Chertow | G. Appel | B. Knebelmann | R. Torra | P. Stenvinkel | L. Mariani | G. Block | K. Nozu | K. Iijima | P. Pergola | C. Meyer | B. Warady | K. Gibson | S. Andreoli | M. Chin | Arnold L. Silva | A. Goldsberry | M. O’Grady | Megan O’Grady